Effects of Positive Hepatitis B Core Antibody and Metabolic Disorders in Hepatocellular Carcinoma in an Endemic Area of Hepatitis B Virus

Effects of Positive Hepatitis B Core Antibody and Metabolic Disorders in Hepatocellular Carcinoma in an Endemic Area of Hepatitis B Virus

Background and Aims This retrospective study aimed to investigate the impact of positive hepatitis B core antibody (anti-HBc) and metabolic disorders on clinical characteristics of hepatocellular carcinoma (HCC) patients in an HBV-endemic area. Methods A total of 1950 consecutive patients newly diag...

Full description

Bibliographic Details
Main Authors:	Hae Lim Lee, Si Hyun Bae, Jaejun Lee, Pil Soo Sung, Sung Won Lee, Jeong Won Jang, Jungmin Lee, Jong Young Choi, Nam Ik Han, Seung Kew Yoon
Format:	Article
Language:	English
Published:	SAGE Publishing 2021-08-01
Series:	Cancer Control
Online Access:	https://doi.org/10.1177/10732748211039758

Similar Items

Real-World Outcomes of Nivolumab in Patients With Unresectable Hepatocellular Carcinoma in an Endemic Area of Hepatitis B Virus Infection
by: Pil Soo Sung, et al.
Published: (2020-06-01)

Reactivation of hepatitis B virus in HBsAg-negative patients with hepatocellular carcinoma.
by: Jeong Won Jang, et al.
Published: (2015-01-01)

Persistence of intrahepatic hepatitis B virus DNA integration in patients developing hepatocellular carcinoma after hepatitis B surface antigen seroclearance
by: Jeong Won Jang, et al.
Published: (2021-01-01)

Anti-fibrotic effects of branched-chain amino acids on hepatic stellate cells
by: Hae Lim Lee, et al.
Published: (2022-01-01)

Comparative Analysis of Lenvatinib and Hepatic Arterial Infusion Chemotherapy in Unresectable Hepatocellular Carcinoma: A Multi-Center, Propensity Score Study
by: Jaejun Lee, et al.
Published: (2021-09-01)

Diffusion-Weighted Magnetic Resonance Imaging in Hepatocellular Carcinoma as a Predictor of a Response to Cisplatin-Based Hepatic Arterial Infusion Chemotherapy
by: Pil Soo Sung, et al.
Published: (2020-11-01)

Noncirrhotic hepatocellular carcinoma: etiology and occult hepatitis B virus infection in a hepatitis B virus-endemic area
by: Chang Woo Shim, et al.
Published: (2017-07-01)

Naturally occurring precore/core region mutations of hepatitis B virus genotype C related to hepatocellular carcinoma.
by: Dong-Won Kim, et al.
Published: (2012-01-01)

Entecavir versus tenofovir in patients with chronic hepatitis B: Enemies or partners in the prevention of hepatocellular carcinoma
by: Sung Won Lee, et al.
Published: (2021-07-01)

A Case of Severe Chronic Active Epstein-Barr Virus Infection with Aplastic Anemia and Hepatitis
by: Ja In Lee, et al.
Published: (2016-01-01)

Comparison of usefulness of clinical diagnostic criteria for hepatocellular carcinoma in a hepatitis B endemic area
by: So Young Bae, et al.
Published: (2012-06-01)

The prevalence and significance of isolated hepatitis B core antibody (anti-HBc) in endemic population
by: Chul S. Hyun, et al.
Published: (2019-05-01)

Tenofovir disoproxil fumarate directly ameliorates liver fibrosis by inducing hepatic stellate cell apoptosis via downregulation of PI3K/Akt/mTOR signaling pathway.
by: Sung Won Lee, et al.
Published: (2021-01-01)

Tenofovir disoproxil fumarate directly ameliorates liver fibrosis by inducing hepatic stellate cell apoptosis via downregulation of PI3K/Akt/mTOR signaling pathway
by: Sung Won Lee, et al.
Published: (2021-01-01)

Association between hepatic steatosis and the development of hepatocellular carcinoma in patients with chronic hepatitis B
by: Yun Bin Lee, et al.
Published: (2019-03-01)

Exosomal miR-125b Exerts Anti-Metastatic Properties and Predicts Early Metastasis of Hepatocellular Carcinoma
by: Hye Seon Kim, et al.
Published: (2021-07-01)

Interferon-free treatment for hepatitis C virus infection induces normalization of extrahepatic type I interferon signaling
by: Pil Soo Sung, et al.
Published: (2018-09-01)

Transarterial infusion of epirubicin and cisplatin combined with systemic infusion of 5-fluorouracil transarterial chemoembolization using doxorubicin for unresectable hepatocellular carcinoma with portal vein tumor thrombosis: a retrospective analysis
by: Sung Won Lee, et al.
Published: (2017-10-01)

MiR-23b-3p suppresses epithelial-mesenchymal transition, migration, and invasion of hepatocellular carcinoma cells by targeting c-MET
by: Na Ri Park, et al.
Published: (2022-10-01)

Whole blood viscosity is associated with extrahepatic metastases and survival in patients with hepatocellular carcinoma.
by: Ji Won Han, et al.
Published: (2021-01-01)

CD133-positive hepatocellular carcinoma in an area endemic for hepatitis B virus infection
by: Lin Chun-Yen, et al.
Published: (2009-09-01)

Hepatitis B Virus Cure: Targets and Future Therapies
by: Hye Won Lee, et al.
Published: (2020-12-01)

Immunological Markers, Prognostic Factors and Challenges Following Curative Treatments for Hepatocellular Carcinoma
by: Soon Kyu Lee, et al.
Published: (2021-09-01)

Dosimetric parameter predicting the deterioration of hepatic function after helical tomotherapy in patients with unresectable locally advanced hepatocellular carcinoma
by: Son Seok Hyun, et al.
Published: (2013-01-01)

Effect of antiviral therapy in reducing perinatal transmission of hepatitis B virus and maternal outcomes after discontinuing them
by: Kwang Il Seo, et al.
Published: (2018-12-01)

Tissue Circular RNA_0004018 and 0003570 as Novel Prognostic Biomarkers for Hepatitis B-Related Hepatocellular Carcinoma
by: Min-Kyu Kang, et al.
Published: (2023-10-01)

Obesity and hepatocellular carcinoma in patients receiving entecavir for chronic hepatitis B
by: Jaemin Lee, et al.
Published: (2016-09-01)

Suboptimal Performance of Hepatocellular Carcinoma Prediction Models in Patients with Hepatitis B Virus-Related Cirrhosis
by: Jae Seung Lee, et al.
Published: (2022-12-01)

Factors associated with the survival outcomes of patients with untreated hepatocellular carcinoma: An analysis of nationwide data
by: Min Jung Kwon, et al.
Published: (2023-03-01)

Analysis of Immune-Related Adverse Events of Atezolizumab and Bevacizumab in Patients with Hepatocellular Carcinoma: A Multicentre Cohort Study
by: Heechul Nam, et al.
Published: (2023-12-01)

Serine Protease HtrA2/Omi Deficiency Impairs Mitochondrial Homeostasis and Promotes Hepatic Fibrogenesis via Activation of Hepatic Stellate Cells
by: Wonhee Hur, et al.
Published: (2019-09-01)

Hepatitis B Core-Related Antigen Is Useful for Predicting Phase and Prognosis of Hepatitis B e Antigen-Positive Patients
by: Han Ah Lee, et al.
Published: (2022-03-01)

Treatment Efficacy and Safety of Tenofovir-Based Therapy in Chronic Hepatitis B: A Real Life Cohort Study in Korea.
by: Hyo Jun Ahn, et al.
Published: (2017-01-01)

Association of Physical Activity with the Risk of Hepatocellular Carcinoma in Patients with Chronic Hepatitis B
by: Ho Soo Chun, et al.
Published: (2021-07-01)

Cost-effectiveness and long-term outcomes of liver transplantation using hepatitis B core antibody-positive grafts with hepatitis B immunoglobulin prophylaxis in Korea
by: Kyeong Deok Kim, et al.
Published: (2021-10-01)

A Case of Reactivation of Hepatitis B and Fulminant Hepatitis which developed 3 months following Chemotherapy Including Rituximab in a Patient with Lymphoma
by: Tae Won Lim, et al.
Published: (2014-12-01)

Risk of hepatocellular carcinoma in untreated patients with chronic hepatitis B: Independent of HBeAg status?
by: Ho Soo Chun, et al.
Published: (2021-07-01)

Comparative Analysis of Atezolizumab Plus Bevacizumab and Hepatic Artery Infusion Chemotherapy in Unresectable Hepatocellular Carcinoma: A Multicenter, Propensity Score Study
by: Ji Hoon Kim, et al.
Published: (2023-08-01)

Diagnostic performance of serum exosomal miRNA-720 in hepatocellular carcinoma
by: Jeong Won Jang, et al.
Published: (2022-03-01)

microRNA-99a Restricts Replication of Hepatitis C Virus by Targeting mTOR and De Novo Lipogenesis
by: Eun Byul Lee, et al.
Published: (2020-06-01)